United Therapeutics (UTHR) Income Statement

Click line-items for a historical chart and %

Net product sales	408.2M
License fees
Total revenues	408.2M
Research and development	45.9M
Selling, general and administrative	100.1M
Cost of product sales	23.6M
Total operating expenses	169.6M
Operating income	238.6M
Interest income
Interest expense	-500K
Equity loss in affiliate
Other, net	1M
Total other (expense) income, net	500K
Income from continuing operations before income taxes	239.1M
Income tax expense	-77.3M
Income from continuing operations
(Loss) income from discontinued operations, net of tax
Loss on disposal of discontinued operations, net of tax
Loss from discontinued operations
Net income
Continuing operations (in dollars per share)
Discontinued operations (in dollars per share)
Net income per basic common share (in dollars per share)	3.75
Continuing operations (in dollars per share)
Discontinued operations (in dollars per share)
Net income per diluted common share (in dollars per share)	3.5
Basic (in shares)	43.2M
Diluted (in shares)	46.2M

Entities mentioned with UTHR

View All Entities